October 24, 2020
Ahmedabad-based Cadila Pharmaceuticals has
appointed V K Singh as Chief Operating Officer
of itsChemical Strategic Business Unit, which
mainly focuses on Active Pharma Ingredients (APIs)
manufactured in India. Singh will be based out of
“Cadila Pharmaceuticals is one of the fastest-growing
pharma companies in the country and is at an inflection
point in its growth trajectory. I am excited about being
part of this journey. I look forward to working closely
with the team at Cadila Pharmaceuticals to chart out new
growth opportunities,” said V K Singh on his association
with Cadila Pharmaceuticals.
Prior to joining Cadila Pharmaceuticals, V K Singh
was Chief Business Officer at Strides Pharma Science.
He has also worked with leading pharma companies such
as Emcure Pharmaceuticals, RPG Life Sciences, Ethypharm
India, and Ranbaxy.